| Today's Open | $23.15 |
|---|---|
| Previous Close | $23.15 |
| Daily Range | $22.13 - $23.23 |
| 52-Week Range | $15.43 - $26.30 |
| Market Cap | $3.0B |
| P/E Ratio | -231.50 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,209,407 |
| Average Daily Volume | 956,346 |
| Current FY EPS | -$0.14 |
Sector
Healthcare
Industry
Drugs
Incyte Corp (INCY) Description
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs. Website: http://www.incyte.com/
News & Commentary
Incyte's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcrip
Incyte's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)Is the Biggest Pharma Company in the World the Best Investment?
Being the world's largest pharmaceutical company has its perks, but does it make Pfizer the best investment?INCY's Top Competitors
(-3.84%)
(2.02%)
(1.31%)
(2.73%)